"So if we consider metabolic disorders as a treatment resistance predictor, this should encourage psychiatrists to put in place a personalised treatment with antidepressant drugs that do not further destabilise metabolism,” explained Bruno Guiard, senior author of the study appeared in the British Journal of Pharmacology.